155 related articles for article (PubMed ID: 38485866)
41. Lymphoepithelial cyst of the pancreas: can common imaging features help to avoid resection?
Khristenko E; Garcia EE; Gaida MM; Hackert T; Mayer P; Kauczor HU; Klauss M
Langenbecks Arch Surg; 2023 Feb; 408(1):82. PubMed ID: 36773118
[TBL] [Abstract][Full Text] [Related]
42. [Management of pancreatic cystic tumors in the Alberto Sabogal Sologuren hospital].
Mori E; Yuen K; Medrano H; Torres J; García C; Montes J
Rev Gastroenterol Peru; 2012; 32(2):169-77. PubMed ID: 23023180
[TBL] [Abstract][Full Text] [Related]
43. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
[TBL] [Abstract][Full Text] [Related]
44. Organ-sparing pancreatectomy for synchronous pancreatic intraductal papillary mucinous neoplasms.
Fathi AH; Uhm S; Hardacre JM
Am Surg; 2014 Dec; 80(12):E339-41. PubMed ID: 25513902
[No Abstract] [Full Text] [Related]
45. Intraductal tubulopapillary neoplasm (ITPN) of the pancreas: A new entity different from intraductal mucinous neoplasm of the pancreas.
Uriarte Terán JI; Prieto Calvo M; García Alberd E; Perfecto Valero A; Valdivieso López A
Cir Esp (Engl Ed); 2023 Sep; 101(9):653-654. PubMed ID: 36261054
[No Abstract] [Full Text] [Related]
46. Immunohistochemical characteristics and malignant progression of hepatic cystic neoplasms in comparison with pancreatic counterparts.
Matsubara T; Sato Y; Sasaki M; Harada K; Nomoto K; Tsuneyama K; Nakamura K; Gabata T; Matsui O; Nakanuma Y
Hum Pathol; 2012 Dec; 43(12):2177-86. PubMed ID: 22705005
[TBL] [Abstract][Full Text] [Related]
47. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas.
Hong SM; Kelly D; Griffith M; Omura N; Li A; Li CP; Hruban RH; Goggins M
Mod Pathol; 2008 Dec; 21(12):1499-507. PubMed ID: 18820670
[TBL] [Abstract][Full Text] [Related]
48. Cystic neoplasia of the pancreas: pathology and biology.
Adsay NV
J Gastrointest Surg; 2008 Mar; 12(3):401-4. PubMed ID: 17957438
[TBL] [Abstract][Full Text] [Related]
49. Branch duct intraductal papillary mucinous neoplasms of the pancreas: watch and wait is not harmless.
Fritz S; Werner J; Büchler MW
Pancreas; 2013 Mar; 42(2):358. PubMed ID: 23407485
[No Abstract] [Full Text] [Related]
50. Intraductal papillary mucinous tumors of the pancreas.
Schmitz-Winnenthal FH; Z'graggen K; Volk C; Schmied BM; Büchler MW
Curr Gastroenterol Rep; 2003 Apr; 5(2):133-40. PubMed ID: 12631453
[TBL] [Abstract][Full Text] [Related]
51. Mucinous cystic lesions of the pancreas. Report of a patient submitted to distal pancreatectomy.
Coppola R; Ripetti V; Caricato M; Caputo D; Ausania F; Arullani A
Chir Ital; 2003; 55(1):105-8. PubMed ID: 12633047
[TBL] [Abstract][Full Text] [Related]
52. Localized type 1 autoimmune pancreatitis superimposed upon preexisting intraductal papillary mucinous neoplasms.
Urata T; Naito Y; Izumi Y; Takekuma Y; Yokomizo H; Nagamine M; Fukuda S; Notohara K; Hifumi M
World J Gastroenterol; 2013 Dec; 19(47):9127-32. PubMed ID: 24379640
[TBL] [Abstract][Full Text] [Related]
53. Racial disparities in rates of invasiveness of resected intraductal papillary mucinous neoplasms in the United States.
Allen WE; Greendyk JD; Alexander HR; Beninato T; Eskander MF; Grandhi MS; In H; Kennedy TJ; Langan RC; Maggi JC; Moore DF; Pitt HA; De S; Haider SF; Ecker BL
Surgery; 2024 May; 175(5):1402-1407. PubMed ID: 38423892
[TBL] [Abstract][Full Text] [Related]
54. ASO Author Reflections: Pancreatic Resection Margins-Chasing Moons.
Shah MM; Datta J; Merchant NB; Kooby DA
Ann Surg Oncol; 2022 Mar; 29(3):1551-1552. PubMed ID: 34997421
[No Abstract] [Full Text] [Related]
55. Patients with a resected pancreatic mucinous cystic neoplasm have a better prognosis than patients with an intraductal papillary mucinous neoplasm: A large single institution series.
Griffin JF; Page AJ; Samaha GJ; Christopher A; Bhaijee F; Pezhouh MK; Peters NA; Hruban RH; He J; Makary MA; Lennon AM; Cameron JL; Wolfgang CL; Weiss MJ
Pancreatology; 2017; 17(3):490-496. PubMed ID: 28416122
[TBL] [Abstract][Full Text] [Related]
56. Fate of the pancreatic remnant after resection for an intraductal papillary mucinous neoplasm: a longitudinal level II cohort study.
Moriya T; Traverso W
Arch Surg; 2012 Jun; 147(6):528-34. PubMed ID: 22351878
[TBL] [Abstract][Full Text] [Related]
57. The "malignant truth" about the recurrence of pancreatic intraductal papillary mucinous neoplasms.
Frampton AE; Pai M; Krell J; Vlavianos P; Jiao LR; Spalding DR
Arch Surg; 2012 Oct; 147(10):977-79; author reply 979-80. PubMed ID: 23070419
[No Abstract] [Full Text] [Related]
58. European experts consensus statement on cystic tumours of the pancreas.
Del Chiaro M; Verbeke C; Salvia R; Klöppel G; Werner J; McKay C; Friess H; Manfredi R; Van Cutsem E; Löhr M; Segersvärd R;
Dig Liver Dis; 2013 Sep; 45(9):703-11. PubMed ID: 23415799
[TBL] [Abstract][Full Text] [Related]
59. Cystic ductal adenocarcinoma of pancreas: an unusual variant.
Gupta N; Krishnan PV; Muzaffar J; Arora A; Anuradha S; Gondal R; Agarwal A; Kar P
Trop Gastroenterol; 2006; 27(3):131-3. PubMed ID: 17310557
[TBL] [Abstract][Full Text] [Related]
60. Unresectable locally advanced pancreatic cancer: treatment with neoadjuvant leucovorin, fluorouracil, irinotecan, and oxaliplatin and assessment of surgical resectability.
Mondo EL; Noel MS; Katz AW; Schoeniger LO; Hezel AF
J Clin Oncol; 2013 Jan; 31(3):e37-9. PubMed ID: 23233707
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
